Patent · US Active

Bone-derived extra cellular matrix gel

US9861662B2 · kind B2 · utility

11Cited by
28References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 3, 2014
Grant dateJan 9, 2018
Priority date
Expiry dateJul 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of manufacturing a bone-derived extracellular matrix (bECM) product are provided. Also provided are bECM products and methods of using those products.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.